Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SANG vs VERS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VERS Captures Overall Composite Edge (48.3 HOLD vs 48.5 HOLD), While SANG Leads 5–0 on Growth & Valuation Pillars

VERS Overall Winner 6-Pillar Tally: SANG 5 – 0 VERS (1 Tie) Matrix Metrics: SANG 8 – 0 VERS

As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. SANG trades at $4.71 (N/M Forward P/E, -6.8% operating margin) versus VERS at $71.45 (N/M Forward P/E, N/A operating margin).

  • Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SANG vs VERS
SANG NASDAQ
Sangoma Technologies Corporation Common Shares
Services-Computer Programming, Data Processing, Etc.
$4.71
-1.15% 1D
Market Cap $159.9M
TTM Revenue $200M
Forward P/E N/M
Beta / 30D Vol 0.04β · 21% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 46.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 57
RSI-14: 57.0 · SMA20: $4.66 · SMA50: $4.39
VERS US Equity Head-to-Head Winner
VERS
Institutional Equity
$71.45
-1.6% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.07β · 24% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 47.0 Fund 47.0 Flow 50.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.3 · SMA20: $73.49 · SMA50: $72.27

6-Pillar Scorecard Institutional Category Breakdown (SANG 5 – 0 VERS)

Columns: Metric · SANG · VERS
1. Valuation Multiples SANG
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.8x N/M
2. Growth & Scale SANG
Revenue Growth (YoY) -21.2% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $200M N/A
Market Cap $159.9M N/A
3. Profitability & Quality SANG
Gross Margin 70.3% N/A
Operating Margin -6.8% N/A
Net Profit Margin -40.5% N/A
Return on Equity (ROE) -37.8% N/A
4. Balance Sheet & Cash Flow SANG
Cash Generation (TTM) $4.9M EBITDA N/A
Cash Flow Margin 2.5% EBITDA Mgn N/A
Net Cash / Leverage $5.24 Book/Sh · -37.8% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 57.2% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat SANG
OpEx & R&D Intensity 77.1% of Rev ($154M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SANG (8) vs VERS (0)
Institutional Metric SANG VERS Criterion Row Edge
Market Capitalization
Scale
$159.9M N/A Larger Scale SANG
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-21.2% N/A Higher Growth SANG
Operating Margin (TTM)
Profitability
-6.8% N/A Higher Margin SANG
Net Profit Margin
Profitability
-40.5% N/A Higher Margin SANG
Return on Equity (ROE)
Capital Efficiency
-37.8% N/A Higher ROE SANG
52-Week Range Position
Momentum
65% ($3–$5) 61% ($51–$85) Stronger Trend SANG
Beta / 30D Volatility
Risk Regime
0.04β · 21% Vol 2.07β · 24% Vol Lower Realized Risk SANG
Unified Institutional Score
Composite Signal
48.5 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite SANG
Trailing 12M Revenue (USD)
Operating Scale
$200M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
70.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$4.9M EBITDA ($5.24 Book/Sh · -37.8% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SANG +25.95 pp
SANG: +26.44% · VERS: +0.49%
3M Horizon SANG +24.04 pp
SANG: +21.05% · VERS: -2.99%
6M Horizon VERS +19.9 pp
SANG: +21.05% · VERS: +40.95%
1Y Horizon VERS +14.64 pp
SANG: -1.66% · VERS: +12.98%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANG vs VERS. Trailing 12-month operating profitability (SANG -6.8% vs VERS N/A) and valuation multiples (SANG N/M vs VERS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SANG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$200M
Gross Margin70.3%
Op. Margin-6.8%
ROE / Fwd P/E-37.8% · N/M
VERS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SANG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SANG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VERS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 57.2%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VERS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SANG Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $159.9M market capitalization and -6.8% operating margin.
OpEx & R&D Reinvestment 77.1% of Rev ($154M)
90D Engineering Disclosures 0 Published
VERS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SANG vs VERS Key Questions & Quantitative Answers

As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. SANG trades at $4.71 (N/M Forward P/E, -6.8% operating margin) versus VERS at $71.45 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

SANG leads the Growth & Scale pillar: SANG posts -21.2% YoY revenue growth and +0.0% YoY earnings growth on $200M TTM revenue (70.3% gross margin, -6.8% operating margin), compared with VERS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SANG generates $200M in USD-normalized revenue versus N/A for VERS. In operating R&D and SG&A reinvestment, SANG deploys 77.1% of Rev ($154M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VERS.

SANG screens cheaper on headline valuation multiples. SANG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (2.5% EBITDA margin), whereas VERS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SANG (-37.8% ROE) versus VERS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, SANG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 21% Vol realized risk). By comparison, VERS carries 57.2% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.07β · 24% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.